Internal Medicine, Nephrology · Fresno, CA
NPI
1184771974
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
568 E Herndon Ave, Suite 201
Fresno, CA, 93720
Phone (559) 228-6600
Groups this clinician bills Medicare through
Medicare paid, 2024
$364K
11,508 services
Medicare patients, 2024
626
Average age 71
Drug cost, 2024
$686K
3,068 prescriptions
Company payments, 2025
$550
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mei-Tsuey Hwang was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 1,020 times for 17 patients. In total Mei-Tsuey Hwang billed 11,508 services in 72 codes, and Medicare paid $364K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,020 | 17 | $6.17 | $6,298 |
| 90960 ESRD Related Services (not dialysis) | Office | 696 | 110 | $278.66 | $194K |
| 99232 Hospital E&M - Subsequent | Facility | 449 | 184 | $62.16 | $28K |
| 99213 Office E&M - Established | Office | 334 | 196 | $53.44 | $18K |
| 36415 Venipuncture Blood Collection | Office | 333 | 121 | $8.65 | $2,880 |
| 84100 Clinical Chemistry | Office | 239 | 114 | $4.65 | $1,111 |
| 83735 Clinical Chemistry | Office | 239 | 114 | $6.57 | $1,570 |
| 80053 Clinical Chemistry | Office | 237 | 113 | $10.35 | $2,453 |
| 85025 Blood Count | Office | 216 | 105 | $7.61 | $1,644 |
| 82570 Clinical Chemistry | Office | 213 | 110 | $5.08 | $1,082 |
| 99214 Office E&M - Established | Office | 192 | 134 | $67.63 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 176 | 103 | $93.69 | $16K |
| 82043 Clinical Chemistry | Office | 157 | 99 | $5.66 | $889 |
| 99231 Hospital E&M - Subsequent | Facility | 119 | 79 | $37.90 | $4,510 |
| 83970 Clinical Chemistry | Office | 118 | 80 | $40.45 | $4,773 |
By year: 2022 $415K for 25,701 services; 2023 $372K for 15,378 services; 2024 $364K for 11,508 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 333 | 121 | $8.65 | $2,880 |
| 83735 Clinical Chemistry | 239 | 114 | $6.57 | $1,570 |
| 84100 Clinical Chemistry | 239 | 114 | $4.65 | $1,111 |
| 80053 Clinical Chemistry | 237 | 113 | $10.35 | $2,453 |
| 85025 Blood Count | 216 | 105 | $7.61 | $1,644 |
| 82570 Clinical Chemistry | 213 | 110 | $5.08 | $1,082 |
| 82043 Clinical Chemistry | 157 | 99 | $5.66 | $889 |
| 83970 Clinical Chemistry | 118 | 80 | $40.45 | $4,773 |
| 84156 Clinical Chemistry | 108 | 59 | $3.60 | $389 |
| 82306 Clinical Chemistry | 95 | 83 | $29.01 | $2,756 |
Medicare prescription drug claims, 2024
In 2024, the drug Mei-Tsuey Hwang prescribed most often to Medicare patients was Amlodipine Besylate, with 264 prescriptions and refills. In total Mei-Tsuey Hwang wrote 3,068 Medicare prescriptions that cost $686K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 264 | 708 | 100 | $1,829 |
| Losartan Potassium Generic | 260 | 716 | 107 | $3,717 |
| Furosemide Generic | 176 | 476 | 70 | $1,214 |
| Prosol Parenteral Amino Acid 20% No.1 | 124 | 124 | Under 11 | $27K |
| Lisinopril Generic | 116 | 329 | 48 | $1,325 |
| Hydralazine Hcl Generic | 105 | 244 | 53 | $1,664 |
| Carvedilol Generic | 95 | 251 | 38 | $787 |
| Atorvastatin Calcium Generic | 91 | 257 | 44 | $821 |
| Sevelamer Carbonate Generic | 85 | 189 | 38 | $24K |
| Velphoro Sucroferric Oxyhydroxide | 78 | 94 | 26 | $202K |
| Farxiga Dapagliflozin Propanediol | 77 | 170 | 28 | $90K |
| Spironolactone Generic | 71 | 186 | 25 | $807 |
| Calcium Acetate Generic | 57 | 99 | 18 | $6,223 |
| Nifedipine Er Nifedipine | 55 | 121 | 22 | $2,256 |
| Telmisartan Generic | 53 | 155 | 20 | $1,118 |
Brand drugs: - claims; generic drugs: 2,432 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mei-Tsuey Hwang $550 ($550 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $191 |
| Travere Therapeutics, Inc. TVTX | 6 | $121 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $56.44 |
| Kyowa Kirin, Inc. 4151.T | 1 | $29.48 |
| Akebia Therapeutics Inc AKBA | 1 | $24.14 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $22.5 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $20.8 |
| Lilly USA, LLC LLY | 1 | $20.05 |
| NxStage Medical, Inc. | 1 | $19.91 |
| Genentech USA, Inc. ROG.SW | 1 | $15.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.